Tus kws kho mob
QP102-20 Introducing eviCore’s new intelliPath® Technology
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2391 - 2400 ntawm 3685
Tus kws kho mob
Upcoming policies effective November 2_ 2020.pdf
Tus kws kho mob
Upcoming policies effective November 30_ 2020.pdf
Tus kws kho mob
QP96-20 Medical Drug Update for New to Market Inclisiran
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020
Tus kws kho mob
QP97-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Factor VIII PA with QL
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020
Tus kws kho mob
QP98-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Fintepla® (fenfluramine) PA with QL
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020
Tus kws kho mob
QP101-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Dojolvi™ PA
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 14, 2020
Tus kws kho mob
P50R1-20 Update: eviCore is Changing Prior Authorization Guidelines used to Review Durable Medical Equipment (DME), Home Health Care (HHC), and Post-Acute Care (PAC) Services for Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2020
Tus kws kho mob
P65-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2020
Tus kws kho mob
P70-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective November 2, 2020
Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2020